Epigenetic Tailoring for the Production of Anti-Infective Cytosporones from the Marine Fungus Leucostoma persoonii

Abstract

Recent genomic studies have demonstrated that fungi can possess gene clusters encoding for the production of previously unobserved secondary metabolites. Activation of these attenuated or silenced genes to obtain either improved titers of known compounds or new ones altogether has been a subject of considerable interest. In our efforts to discover new chemotypes that are effective against infectious diseases, including malaria and methicillin-resistant Staphylococcus aureus (MRSA), we have isolated a strain of marine fungus, Leucostoma persoonii, that produces bioactive cytosporones. Epigenetic modifiers employed to activate secondary metabolite genes resulted in enhanced production of known cytosporones B ( 1, 360%), C ( 2, 580%) and E ( 3, 890%), as well as the production of the previously undescribed cytosporone R ( 4). Cytosporone E was the most bioactive, displaying an IC ₉₀ of 13 µM toward Plasmodium falciparum, with A549 cytotoxicity IC ₉₀ of 437 µM, representing a 90% inhibition therapeutic index (TI ₉₀ = IC ₉₀ A459/IC ₉₀ P. falciparum) of 33. In addition, cytosporone E was active against MRSA with a minimal inhibitory concentration (MIC) of 72 µM and inhibition of MRSA biofilm at roughly half that value (minimum biofilm eradication counts, MBEC90, was found to be 39 µM).